Chinese scientists discover gene associated with prostate cancer
BEIJING - Chinese scientists have identified a new gene strongly associated with prostate cancer, offering new methods for diagnosis and treatment of the disease.
The newly identified biomarker, PCSEAT, was discovered by scientists from Suzhou Institute of Biomedical Engineering and Technology.
The research reveals that PCSEAT is overexpressed in prostate cancer patients, indicating that PCSEAT may be a potential therapeutic target. The research was published in the journal "Biochemical and Biophysical Research Communications" in May.
Based on the research, they have developed an early diagnosis for prostate cancer and applied for a patent. The application can significantly improve the accuracy of prostate cancer diagnosis and reduce the cost of diagnosis and treatment.
China has seen increasing cases of prostate cancer in recent years.
- China completes gene expression profiles of human digestive tract
- UK and China inject 47 million pounds into fight against superbugs
- Chinese scientists develop bionic nanodevice to combat breast cancer
- Mutation discovery could help prevent genetic disorders
- Researchers find fungus used in traditional medicine can fight cancer
- 17 rescued Filipino crew members transferred
- Team of Chinese, US scientists identifies key tumor cell state driving cancer growth, drug resistance
- China successfully conducts first metal 3D printing experiment in space
- Debt-ridden children's hospital gains strong public support, but future still uncertain
- China hands over 17 Filipino sailors from shipwreck to Philippines
- Topography, extreme rainfall causes of Guizhou landslide, report says
